PIH3 RISK OF WEIGHT GAIN WITH THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) AND ATYPICAL ANTIPSYCHOTICS (SGA) COMBINATION TREATMENT IN CHILDREN AND ADOLESCENTS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72880-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)72880-1/fulltext
Title :
PIH3 RISK OF WEIGHT GAIN WITH THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) AND ATYPICAL ANTIPSYCHOTICS (SGA) COMBINATION TREATMENT IN CHILDREN AND ADOLESCENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72880-1&doi=10.1016/S1098-3015(10)72880-1
First page :
Section Title :
Open access? :
No
Section Order :
452